Stay updated with breaking news from Duo Extend. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Philips announced the first U.S. patient was successfully treated at Sanger Heart & Vascular Clinic with the Duo Venus Stent System, an implantable medical device for chronic venous insufficiency (CVI).
Four late-breaking clinical trial outcomes from The VEINS Conference presented results from the CLOUT Registry, VIVID Trial, DEXTERITY-AFP Trial, and Venous Thromboembolism Treatment were present during the The VEINS Conference, taking place Oct. 28-30 in Las Vegas, NV.
/PRNewswire/ -- The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and...